.STUDY EMPHASIZE.06 August 2024.
A huge randomized controlled test with cisgender ladies highlights the difficulties of adherence to a regular oral preexposure prevention regiment and also shows that twice-yearly treatment of lenacapavir may preserve helpful HIV prevention levels over 6 months.